Project Grant R01AI194449
Award Date
7/22/25
Completion Date
6/30/29
Dollars Obligated
$3.2M
Federal Agency
National Institute of Allergy and Infectious Diseases
Federal Grant Program
93.855
Assistance Type
Project Grant
Place of Performance
Davis, CA, USA
Similar Awards
This $133,664 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) supports research to characterize the network of vector-host-virus interactions within wetland ecosystems in Argentina. The key objectives are to: Identify host bloodmeals in wetland mosquitoes to elucidate the potential viral flow between resident and migratory birds. Analyze the previous exposure of migratory and...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $3,248,576 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the University of California, Davis. The grant, awarded on July 25, 2025, will fund research to understand the cross-protective efficacy of the recently FDA-approved IXCHIQ live attenuated chikungunya virus vaccine against other alphavirus species, assess the vaccine's infectivity and transmissibility in mosquitoes, and...
The National Science Foundation (NSF) awarded a 5-year, $977,779 Project Grant under the Biological Sciences (CFDA 47.074) program to the University of California, Santa Barbara (UCSB) to investigate how climate change and land use shifts may impact the synchronization between mosquito vectors and bird hosts, and the implications for West Nile Virus transmission. The research will leverage a combination of modeling, causal inference, citizen science, and field data collection to understand how...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $790,000.00 in funding to the Regents of the University of Minnesota to conduct research on the immune response to West Nile virus (WNV) and the factors that influence the development of neuroinvasive disease. The goal is to gain a molecular understanding of WNV neuroinvasion, central nervous system immunity, and the...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $401,185 Project Grant under the Allergy and Infectious Diseases Research federal grant program (CFDA 93.855) to the Board of Regents of the Nevada System of Higher Education, operating through the University of Nevada, Reno. The grant supports research to define the mechanism of action of the broadly-active antiviral mosquito protein ABRAVO. The project aims to generate new tools to study ABRAVO, determine the key...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $166,162 Project Grant under the Allergy and Infectious Diseases Research (CFDA 93.855) federal grant program to the University of California, Davis (UC Davis). The grant, awarded on September 15, 2024, will support research to characterize the ecological drivers and longitudinal dynamics of coronavirus cross-species transmission in bat populations. The project aims to provide insights into the origins and emergence of...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $648,924 to Iowa State University of Science and Technology to conduct research on the role of mosquito extracellular vesicles in malaria parasite killing and immune priming. The project aims to obtain a mechanistic understanding of how these extracellular vesicles function within the mosquito immune system...
The federal Project Grant award of $873,362.00 was provided by the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), to East Carolina University to study the socioeconomic impacts of La Crosse encephalitis in western North Carolina. The research project will assess the acute and long-term physical, social, and cognitive impacts of La Crosse encephalitis on survivors and their families, determine the direct and...
The University of New Mexico received a $430,251 Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) to conduct genetic mapping research on advanced intercross lines of the Biomphalaria glabrata snail, a vector for the schistosomiasis parasite. The research aims to identify genomic regions and genes that regulate schistosome resistance and per capita cercarial production in these snails, with the goal of...
This $583,047 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports research to understand how Rift Valley Fever Virus (RVFV) disseminates from the site of infection in the skin to the central nervous system (CNS). The project aims to establish the routes and mechanisms by which RVFV invades the CNS following peripheral exposure, using novel rodent CNS infection models...